Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia, the unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2025 along with the Limited Review Report for the said period.
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Solara Active Pharma Sciences has filed its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, along with the Limited Review Report from the auditors. This is a routine quarterly compliance filing required of all listed companies under SEBI's Listing Regulations. No specific revenue, profit, or margin figures have been disclosed in the filing notice itself.
No immediate stock-moving impact from this announcement alone — investors should review the detailed results and Limited Review Report for any surprises in revenue, margins, or auditor qualifications before drawing conclusions.